Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer is a lethal disease due to its late phase discovery. Any steps towards improving early diagnostics will dramatically increase survival rates. To identify new ovarian cancer biomarker panels, we need to focus on early-stage disease and all histologic subtypes. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liljedahl, Leena, Malmström, Johan, Kristjansdottir, Björg, Waldemarson, Sofia, Sundfeldt, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616310/
https://www.ncbi.nlm.nih.gov/pubmed/34830868
http://dx.doi.org/10.3390/cancers13225713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616310/
https://www.ncbi.nlm.nih.gov/pubmed/34830868
http://dx.doi.org/10.3390/cancers13225713

Ejemplares similares